These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10423109)
1. The importance of drug combinations for effective control of hypertension. Chalmers J Clin Exp Hypertens; 1999; 21(5-6):875-84. PubMed ID: 10423109 [TBL] [Abstract][Full Text] [Related]
2. The role of combination therapy in the treatment of hypertension. Moser M; Black HR Am J Hypertens; 1998 Jun; 11(6 Pt 2):73S-78S; discussion 95S-100S. PubMed ID: 9655566 [TBL] [Abstract][Full Text] [Related]
3. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy in hypertension. Gorostidi M; de la Sierra A Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510 [TBL] [Abstract][Full Text] [Related]
6. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
7. [What is safe in the therapy of hypertensive heart disease?]. Motz W; Strauer BE Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983 [No Abstract] [Full Text] [Related]
8. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022 [TBL] [Abstract][Full Text] [Related]
9. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Morgan TO; Anderson AI; MacInnis RJ Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235 [TBL] [Abstract][Full Text] [Related]
10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of myocardial ischemia with reference to blood pressure values]. Schneeweiss A; Wiegand V Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187 [No Abstract] [Full Text] [Related]
13. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension. Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166 [TBL] [Abstract][Full Text] [Related]